These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 26875533)
1. Successful treatment of pachydermoperiostosis with etoricoxib in a patient with a homozygous splice-site mutation in the SLCO2A1 gene. Li Z; Yang Q; Yang Y; Wang D; Wang S Br J Dermatol; 2019 Mar; 180(3):682-684. PubMed ID: 26875533 [No Abstract] [Full Text] [Related]
2. Primary Hypertrophic Osteoarthropathy With SLCO2A1 Mutation in a Chinese Patient Successfully Treated With Etoricoxib. Sun F; Guo L; Ye S J Clin Rheumatol; 2018 Apr; 24(3):164-167. PubMed ID: 29239930 [No Abstract] [Full Text] [Related]
3. Clinical, Biochemical, and Genetic Features of 41 Han Chinese Families With Primary Hypertrophic Osteoarthropathy, and Their Therapeutic Response to Etoricoxib: Results From a Six-Month Prospective Clinical Intervention. Li SS; He JW; Fu WZ; Liu YJ; Hu YQ; Zhang ZL J Bone Miner Res; 2017 Aug; 32(8):1659-1666. PubMed ID: 28425581 [TBL] [Abstract][Full Text] [Related]
4. Complete form of pachydermoperiostosis with cutis verticis gyrata resulting from the Li X; Hao D; Li-Ling J; Jiang X Indian J Dermatol Venereol Leprol; 2019; 85(6):681. PubMed ID: 30880718 [No Abstract] [Full Text] [Related]
5. Pachydermoperiostosis of the complete type: A novel missense mutation c.101T > C in the SLCO2A1 gene. Ma W; Guo S; Li Y; Li Z Eur J Med Genet; 2017 Aug; 60(8):433-436. PubMed ID: 28602931 [TBL] [Abstract][Full Text] [Related]
6. A novel homozygous mutation in the SLCO2A1 gene is associated with severe primary hypertrophic osteoarthropathy phenotype in a Saudi patient. Ayoub N; Al-Khenaizan S; Sonbol H; Albreakan R; AlSufyani M; AlBalwi M Int J Dermatol; 2015 Jun; 54(6):e233-5. PubMed ID: 25601417 [No Abstract] [Full Text] [Related]
7. A novel homozygous mutation in the SLCO2A1 gene causing pachydermoperiostosis: Efficacy of hydroxychloroquine treatment. Alessandrella A; Della Casa R; Alessio M; Puente Prieto J; Strisciuglio P; Melis D Am J Med Genet A; 2018 May; 176(5):1253-1257. PubMed ID: 29681086 [TBL] [Abstract][Full Text] [Related]
8. The complete type of pachydermoperiostosis: a novel nonsense mutation p.E141* of the SLCO2A1 gene. Niizeki H; Shiohama A; Sasaki T; Seki A; Kabashima K; Otsuka A; Kosaki K; Ogo A; Yamada T; Miyasaka M; Matsuoka K; Hirakiyama A; Okuyama T; Matsuda M; Nakabayashi K; Tanese K; Ishiko A; Amagai M; Kudoh J J Dermatol Sci; 2014 Sep; 75(3):193-5. PubMed ID: 24929850 [No Abstract] [Full Text] [Related]
9. Identification of mutations in the prostaglandin transporter gene SLCO2A1 and its phenotype-genotype correlation in Japanese patients with pachydermoperiostosis. Sasaki T; Niizeki H; Shimizu A; Shiohama A; Hirakiyama A; Okuyama T; Seki A; Kabashima K; Otsuka A; Ishiko A; Tanese K; Miyakawa S; Sakabe J; Kuwahara M; Amagai M; Okano H; Suematsu M; Kudoh J J Dermatol Sci; 2012 Oct; 68(1):36-44. PubMed ID: 22906430 [TBL] [Abstract][Full Text] [Related]
11. Pachydermoperiostosis in an African patient caused by a Chinese/Japanese SLCO2A1 mutation-case report and review of literature. Madruga Dias JA; Rosa RS; Perpétuo I; Rodrigues AM; Janeiro A; Costa MM; Gaião L; Pereira da Silva JA; Fonseca JE; Miltenberger-Miltenyi G Semin Arthritis Rheum; 2014 Feb; 43(4):566-9. PubMed ID: 24012041 [TBL] [Abstract][Full Text] [Related]
12. Complete form of pachydermoperiostosis with SLCO2A1 gene mutation in a Korean family. Kim HJ; Koo KY; Shin DY; Kim DY; Lee JS; Lee MG J Dermatol; 2015 Jun; 42(6):655-7. PubMed ID: 25810087 [No Abstract] [Full Text] [Related]
13. Complete type of pachydermoperiostosis with a novel mutation c.510G>A of the SLCO2A1 gene. Nakazawa S; Mori T; Niizeki H; Nakabayashi K; Tokura Y J Dermatol; 2017 Dec; 44(12):1411-1412. PubMed ID: 28026033 [No Abstract] [Full Text] [Related]
14. Case of pachydermoperiostosis with solute carrier organic anion transporter family, member 2A1 (SLCO2A1) mutations. Minakawa S; Kaneko T; Niizeki H; Mizukami H; Saito Y; Nigawara T; Kurose R; Nakabayashi K; Kabashima K; Sawamura D J Dermatol; 2015 Sep; 42(9):908-10. PubMed ID: 26072672 [No Abstract] [Full Text] [Related]
15. Identification of the Mutations in the Prostaglandin Transporter Gene, SLCO2A1 and Clinical Characterization in Korean Patients with Pachydermoperiostosis. Lee S; Park SY; Kwon HJ; Lee CH; Kim OH; Rhee Y J Korean Med Sci; 2016 May; 31(5):735-42. PubMed ID: 27134495 [TBL] [Abstract][Full Text] [Related]
16. Pachydermoperiostosis: The value of molecular diagnosis. Seta V; Capri Y; Battistella M; Bagot M; Bourrat E Ann Dermatol Venereol; 2017 Dec; 144(12):799-803. PubMed ID: 28916395 [TBL] [Abstract][Full Text] [Related]
17. Exome sequencing identifies SLCO2A1 mutations as a cause of primary hypertrophic osteoarthropathy. Zhang Z; Xia W; He J; Zhang Z; Ke Y; Yue H; Wang C; Zhang H; Gu J; Hu W; Fu W; Hu Y; Li M; Liu Y Am J Hum Genet; 2012 Jan; 90(1):125-32. PubMed ID: 22197487 [TBL] [Abstract][Full Text] [Related]
18. A case of complete form of pachydermoperiostosis with SLCO2A1 mutations. Xu C; Tao Y Eur J Dermatol; 2021 Apr; 31(2):249-251. PubMed ID: 34001473 [No Abstract] [Full Text] [Related]
19. A novel mutation in the SLCO2A1 gene in a Chinese family with pachydermoperiostosis. Xiao J; Zhang DD; Zhang L Australas J Dermatol; 2019 Nov; 60(4):e348-e350. PubMed ID: 30931527 [No Abstract] [Full Text] [Related]
20. The novel SLCO2A1 heterozygous missense mutation p.E427K and nonsense mutation p.R603* in a female patient with pachydermoperiostosis with an atypical phenotype. Niizeki H; Shiohama A; Sasaki T; Seki A; Kabashima K; Otsuka A; Takeshita M; Hirakiyama A; Okuyama T; Tanese K; Ishiko A; Amagai M; Kudoh J Br J Dermatol; 2014 May; 170(5):1187-9. PubMed ID: 24329728 [No Abstract] [Full Text] [Related] [Next] [New Search]